Current stage?-Stage III - Page 28 of 33 Posts on Medivizor
Navigation Menu

Current stage?-Stage III Posts on Medivizor

Which factors can determine the prognosis in melanoma?

Which factors can determine the prognosis in melanoma?

Posted by on Oct 1, 2013 in Melanoma | 0 comments

In a nutshell This study evaluated which factors can help determine the prognosis of melanoma patients with skin metastases. Some background Melanoma is a type of skin cancer that originates in the pigmented cells of the skin called melanocytes. The 5-year survival rates of patients with melanoma can vary widely, and the prognosis of the disease...

Read More

Can chemotherapy make inoperable cancer operable?

Can chemotherapy make inoperable cancer operable?

Posted by on Sep 29, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of chemotherapy to treat inoperable (that cannot be removed through surgery) metastases from colorectal cancer (CRC). Some background When CRC is discovered early, the preferred method of treatment is surgery to remove the cancer along with some surrounding healthy tissue. Chemotherapy is often...

Read More

Better surveillance to detect early recurrence

Better surveillance to detect early recurrence

Posted by on Sep 28, 2013 in Melanoma | 0 comments

In a nutshell This study evaluated whether there are specific, high-risk periods a melanoma can return (recur) and spread to distant organs of the body (metastasize). Some background Melanoma is a type of skin cancer that originates in the melanocytes (pigment producing cells of the skin). Often, particularly in the early stages, when the melanoma...

Read More

Can beta blockers slow cancer?

Can beta blockers slow cancer?

Posted by on Sep 22, 2013 in Lung cancer | 0 comments

In a nutshell This study examined whether use of beta-blockers could slow the progression of non small-cell lung cancer. Some background Treatment of non small-cell lung cancer (NSCLC) is often limited due to the rapid progression of the cancer and high recurrence rates. The mechanisms responsible for the rapid spread of NSCLC are unclear, but the...

Read More

Could metformin be used to treat cancer?

Could metformin be used to treat cancer?

Posted by on Sep 22, 2013 in Prostate cancer | 0 comments

In a nutshell This study investigated the relationship between the use of metformin (Glucophage) and prostate cancer mortality. Some background Metformin is a drug commonly used in the management of diabetes. Metformin works by suppressing glucose production in the liver and increasing the body's sensitivity to insulin. Recent studies have...

Read More

Can biology of the cancer predict survival?

Can biology of the cancer predict survival?

Posted by on Sep 21, 2013 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether the biology of the cancer called mucinous histology can be used to predict the outcomes of patients with colorectal cancer. The study also evaluated the association between mucinous adenocarcinoma and microsatellite instability. Some background Mucinous histology (MH) is a microscopic observation of...

Read More

Evaluating long-term outcomes of patients with advanced melanoma treated with ipilimumab

Evaluating long-term outcomes of patients with advanced melanoma treated with ipilimumab

Posted by on Sep 8, 2013 in Melanoma | 0 comments

In a nutshell This study investigated the long-term safety and efficacy of ipilimumab in patients with advanced melanoma. Some background Patients with advanced melanoma (cancer of the pigmented cells of the skin, called melanocytes, that has invaded beyond the skin or has spread to the lymph nodes or other organs of the body) often benefit from...

Read More

Higher levels of microRNA-21 linked to better survival and lower risk of recurrence in colorectal cancer

Higher levels of microRNA-21 linked to better survival and lower risk of recurrence in colorectal cancer

Posted by on Sep 8, 2013 in Colorectal cancer | 0 comments

In a nutshell In this study, researchers examined whether levels of a blood marker called microRNA-21 could help predict colorectal cancer (CRC) recurrences. Such information may help select which patients require more intensive follow-up after treatment. Some background MicroRNA consists of small pieces of RNA, a molecule that tells the...

Read More

A trial comparing three adjuvant chemotherapy regimens in the treatment of women with breast cancer

A trial comparing three adjuvant chemotherapy regimens in the treatment of women with breast cancer

Posted by on Aug 23, 2013 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness of three adjuvant chemotherapy regimens used in the treatment of node positive breast cancer. Some background Adjuvant chemotherapy refers to chemotherapy given in addition to surgery in an attempt to destroy any remaining cancer cells and to prevent cancer recurrence. Adjuvant chemotherapy is...

Read More